Eledon Pharmaceuticals (ELDN) Cash from Investing Activities (QoQ) (2014 - 2026)
Eledon Pharmaceuticals (ELDN) Cash from Investing Activities (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Eledon Pharmaceuticals |
401.35 Mn |
185.32 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
129.11% |
| Dec 31, 2025 |
-264.95% |
| Sep 30, 2025 |
-17.07% |
| Jun 30, 2025 |
284.33% |
| Mar 31, 2025 |
108.21% |
| Dec 31, 2024 |
-270.11% |
| Sep 30, 2024 |
35.71% |
| Jun 30, 2024 |
-303.55% |
| Mar 31, 2024 |
-2.91% |
| Dec 31, 2023 |
140.26% |
| Jun 30, 2017 |
337.76% |
| Mar 31, 2017 |
33,169.23% |
| Dec 31, 2016 |
750.00% |
| Sep 30, 2016 |
-128.57% |
| Jun 30, 2016 |
141.18% |
| Mar 31, 2016 |
94.62% |
| Dec 31, 2015 |
98.01% |
| Sep 30, 2015 |
34.74% |
| Jun 30, 2015 |
-53,888.89% |
| Sep 30, 2014 |
-2,516.67% |
